Christophe Hilbert https://www.epmmagazine.com/topics/christophe-hilbert/index.rss en-gb © Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved. Tue, 27 Jul 2021 10:00:00 -0000 Christophe Hilbert Cell and gene therapies: Why new approaches to pricing and reimbursement are needed in Europe Christophe Hilbert, senior manager of Access, Value, and Evidence Strategy, Europe at bluebird bio explores the problems of pricing and reimbursement for gene and cell therapies in Europe. https://www.epmmagazine.com/pharmaceutical-industry-insights/biopharma-news/cell-and-gene-therapies-why-new-approaches-to-pricing-and-re/ https://www.epmmagazine.com/pharmaceutical-industry-insights/biopharma-news/cell-and-gene-therapies-why-new-approaches-to-pricing-and-re/ Tue, 27 Jul 2021 10:00:00 -0000 Euro.png